中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2011年
5期
634-637
,共4页
马艳%姜婷%刘楚娟%肖波
馬豔%薑婷%劉楚娟%肖波
마염%강정%류초연%초파
外科手术,微创性/方法%颅内出血,高血压性/外科学
外科手術,微創性/方法%顱內齣血,高血壓性/外科學
외과수술,미창성/방법%로내출혈,고혈압성/외과학
Surgical procedures,minimally invasive/MT%Intracranial hemorrhage,hypertensive/SU
目的 探讨软通道与硬通道微创技术治疗高血压脑出血的临床疗效及其相关并发症.方法 纳入122例有微创手术指征的高血压脑出血患者,其中软通道治疗组64例,硬通道治疗组58例.观察两组病例治疗后的临床疗效、保留置管时间及其手术相关并发症,如再出血、颅内感染、颅内积气、脑脊液漏、穿刺部位感染等.结果 软通道组治疗前NIHSS评分18.05±7.77,治疗后NIHSS评分7.57±4.68,住院期间病死率17.19%,血肿穿刺置管天数(4.35±1.56)d,侧脑室穿刺置管天数(7.67±2.37)d,再出血4例,颅内感染3例;硬通道组治疗前NIHSS评分18.38±9.02,治疗后NIHSS评分8.02±4.84,住院期间病死率20.69%,血肿穿刺置管天数(4.07±1.49)d,侧脑室穿刺置管天数(8.17±2.55)d,再出血9例,颅内感染2例,两组各项指标比较,差异均无统计学意义(P>0.05).结论 软通道与硬通道微创技术治疗高血压脑出血具有同等的临床应用价值.
目的 探討軟通道與硬通道微創技術治療高血壓腦齣血的臨床療效及其相關併髮癥.方法 納入122例有微創手術指徵的高血壓腦齣血患者,其中軟通道治療組64例,硬通道治療組58例.觀察兩組病例治療後的臨床療效、保留置管時間及其手術相關併髮癥,如再齣血、顱內感染、顱內積氣、腦脊液漏、穿刺部位感染等.結果 軟通道組治療前NIHSS評分18.05±7.77,治療後NIHSS評分7.57±4.68,住院期間病死率17.19%,血腫穿刺置管天數(4.35±1.56)d,側腦室穿刺置管天數(7.67±2.37)d,再齣血4例,顱內感染3例;硬通道組治療前NIHSS評分18.38±9.02,治療後NIHSS評分8.02±4.84,住院期間病死率20.69%,血腫穿刺置管天數(4.07±1.49)d,側腦室穿刺置管天數(8.17±2.55)d,再齣血9例,顱內感染2例,兩組各項指標比較,差異均無統計學意義(P>0.05).結論 軟通道與硬通道微創技術治療高血壓腦齣血具有同等的臨床應用價值.
목적 탐토연통도여경통도미창기술치료고혈압뇌출혈적림상료효급기상관병발증.방법 납입122례유미창수술지정적고혈압뇌출혈환자,기중연통도치료조64례,경통도치료조58례.관찰량조병례치료후적림상료효、보류치관시간급기수술상관병발증,여재출혈、로내감염、로내적기、뇌척액루、천자부위감염등.결과 연통도조치료전NIHSS평분18.05±7.77,치료후NIHSS평분7.57±4.68,주원기간병사솔17.19%,혈종천자치관천수(4.35±1.56)d,측뇌실천자치관천수(7.67±2.37)d,재출혈4례,로내감염3례;경통도조치료전NIHSS평분18.38±9.02,치료후NIHSS평분8.02±4.84,주원기간병사솔20.69%,혈종천자치관천수(4.07±1.49)d,측뇌실천자치관천수(8.17±2.55)d,재출혈9례,로내감염2례,량조각항지표비교,차이균무통계학의의(P>0.05).결론 연통도여경통도미창기술치료고혈압뇌출혈구유동등적림상응용개치.
Objective Soft and hard channel minimally invasive interventions for patients with hypertensive intracerebral hemorrhage have been used for many years. A retrospective study was performed to evaluate the superiority of these two methods. Methods 122 patients with hypertensive intracerebral hemorrhage were included in this retrospective study, 64 cases in soft channel group and 58 cases in hard channel group. The clinical effects were compared; catheter retention time and complications of the minimally invasive surgery were also observed in these two groups. Results In soft channel group, NIHSS before the treatment was 18.05±7.77, and NIHSS after the treatment was 7.57±4.68. The mortality was 17.19%. The catheter retention time in hematoma puncture was (4.35±1.56)days, and the catheter retention time in ventricle puncture was (7.67±2.37)days. There were 4 cases of rebleeding and 3 cases of intracranial infection. In hard channel group, NIHSS before the treatment was 18.38±9.02, and NIHSS after the treatment was 8.02±4.84. The mortality was 20.69%. The catheter retention time in hematoma puncture was (4.07±1.49)days, and the catheter retention time in ventricle puncture was (8.17±2.55)days. There were 9 cases of rebleeding and 2 cases of intracranial infection. The differences were not statistically significant (P>0.05). Conclusions Soft and hard channel minimally invasive interventions of hypertensive cerebral hemorrhage have the same clinical value.